| James R Hanley Iii, MD | |
|
1514 Jefferson Highway, New Orleans, LA 70121 | |
| (504) 842-4000 | |
| Not Available |
| Full Name | James R Hanley Iii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Pediatric Emergency Medicine |
| Location | 1514 Jefferson Highway, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053308791 | NPI | - | NPPES |
| 3810235 | Medicaid | TN | |
| 009910809 | Medicaid | AL | |
| 515541854 | Other | AL | BCBS - 1504 SPRINGHILL |
| 04029336 | Medicaid | MS | |
| 1807711 | Medicaid | LA |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
National Institutes of Health researchers have discovered a rare and sometimes lethal inflammatory disease - otulipenia - that primarily affects young children. They have also identified anti-inflammatory treatments that ease some of the patients' symptoms: fever, skin rashes, diarrhea, joint pain and overall failure to grow or thrive.
Northwestern Memorial HealthCare has completed its formal plans to affiliate with Lake County's Lake Forest Hospital. Northwestern's health system has obtained both federal and state approvals to proceed with an affiliation agreement that will make Lake Forest Hospital a wholly owned entity of Northwestern Memorial HealthCare along with Northwestern Memorial Hospital on February 1, 2010.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
A dozen Ludwig scientists from around the world presented the latest advancements in basic and clinical cancer research at this week's American Association for Cancer Research (AACR) Annual Meeting 2013. Progress in immunotherapy and epigenetics led the program with important diagnostic and treatment implications for emerging cancer therapy.
› Verified 3 days ago
| Entity Name | Belle Chasse Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851714075 PECOS PAC ID: 7113140070 Enrollment ID: O20140521001580 |
News Archive
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
National Institutes of Health researchers have discovered a rare and sometimes lethal inflammatory disease - otulipenia - that primarily affects young children. They have also identified anti-inflammatory treatments that ease some of the patients' symptoms: fever, skin rashes, diarrhea, joint pain and overall failure to grow or thrive.
Northwestern Memorial HealthCare has completed its formal plans to affiliate with Lake County's Lake Forest Hospital. Northwestern's health system has obtained both federal and state approvals to proceed with an affiliation agreement that will make Lake Forest Hospital a wholly owned entity of Northwestern Memorial HealthCare along with Northwestern Memorial Hospital on February 1, 2010.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
A dozen Ludwig scientists from around the world presented the latest advancements in basic and clinical cancer research at this week's American Association for Cancer Research (AACR) Annual Meeting 2013. Progress in immunotherapy and epigenetics led the program with important diagnostic and treatment implications for emerging cancer therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James R Hanley Iii, MD 1514 Jefferson Highway, New Orleans, LA 70121 Ph: (504) 842-4000 | James R Hanley Iii, MD 1514 Jefferson Highway, New Orleans, LA 70121 Ph: (504) 842-4000 |
News Archive
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
National Institutes of Health researchers have discovered a rare and sometimes lethal inflammatory disease - otulipenia - that primarily affects young children. They have also identified anti-inflammatory treatments that ease some of the patients' symptoms: fever, skin rashes, diarrhea, joint pain and overall failure to grow or thrive.
Northwestern Memorial HealthCare has completed its formal plans to affiliate with Lake County's Lake Forest Hospital. Northwestern's health system has obtained both federal and state approvals to proceed with an affiliation agreement that will make Lake Forest Hospital a wholly owned entity of Northwestern Memorial HealthCare along with Northwestern Memorial Hospital on February 1, 2010.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
A dozen Ludwig scientists from around the world presented the latest advancements in basic and clinical cancer research at this week's American Association for Cancer Research (AACR) Annual Meeting 2013. Progress in immunotherapy and epigenetics led the program with important diagnostic and treatment implications for emerging cancer therapy.
› Verified 3 days ago
Ms. Misty T Wetzel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 963 Taft Pl, New Orleans, LA 70119 Phone: 504-309-4246 | |
Jasmine Sha'dey Holmes, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Canal Street, D&t Bldg., 2nd Floor, Suite 2720, New Orleans, LA 70112 Phone: 504-702-2287 Fax: 504-702-2500 | |
Dr. Susan Diane Taylor, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1401 Foucher St, New Orleans, LA 70115 Phone: 504-897-2850 | |
Lisa Birdsall Fort, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3460 | |
Ms. Elizabeth Anne Clement, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2020 Gravier St, 7th Floor, New Orleans, LA 70112 Phone: 504-903-3594 | |
Sarah Elizabeth Griffin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Canal St, New Orleans, LA 70112 Phone: 347-271-0784 | |
Colin Devlin, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5022 Laurel St, New Orleans, LA 70115 Phone: 781-696-2226 |